CURALEAF, INC.
WAKEFIELD, MA

CURALEAF, INC., Wakefield
PALLIATECH, INC.

best and most trusted cannabis-based company in the U.S. by: Delivering exceptional user experiences by continually innovating high quality, reliable cannabis products and services Empowering patients and consumers by being the industry’s leading educational resource, allowing them to make the best product choices Stuart is a seasoned operational leader with over 25 years of expertise in global supply chain, operations start-up, acquisitions, and new product commercialization at market leaders. He joined PalliaTech from Hostess Brands where he was the SVP/COO of Operations for the past two years. Prior to Hostess, he held global senior operational leadership positions at The Original Cakerie, a private Canadian company, Fresh Express/ Chiquita and ConAgra. Stuart holds a Bachelor’s degree in Mechanical Engineering Technologies from University of Toledo and a Master’s of Science from Central Michigan University. Jon Faucher is an accomplished finance professional with experience working in fast-paced small to mid-sized high tech organizations. He brings extensive experience developing and implementing financial systems to drive business decisions. Prior to joining PalliaTech, Jon held finance positions at BionX Medical Technologies and Reveal Imaging Technologies, where he was responsible for all aspects of accounting and finance, focusing on cost reduction programs, ERP implementations, and government audits. Senior Vice President, Research and Product Development Robert Winnicki is a leading cannabis chemist with expertise in extraction, formulation and cannabis product manufacturing. With PalliaTech’s Medical Advisory Board, Robert Winnicki leads PalliaTech’s product development team. Robert Winnicki has led research in Canada and the U.S., particularly in the areas of synthetic biology of cannabinoid production; formulation of liquid and powder-based cannabinoid formulations; chemical synthesis of USP grade cannabinoids at the 500-gram scale; outdoor cultivation of hemp including the extraction and purification of CBD and plant tissue culture aimed at producing genetically modified cannabis. Prior to joining PalliaTech, Robert Winnicki was a certified laboratory director in Colorado and former head of R&D in medical marijuana cloning and cannabinoid synthesis. Peter Clateman has more than 20 years legal experience in investing and investment funds, including over 15 years as general counsel. He has served as GC and CCO of The Sputnick Group and Renaissance Capital, as well as VR Capital, an award winning distressed asset fund with over $2bn AUM. Peter Clateman also served as head of Legal and was a Management Board Member of UC Rusal during its acquisition of SUAL and assets of Glencore to become the world’s biggest aluminum company. Prior to that he was an associate with Skadden Arps Slate Meagher and Flom. Peter Clateman received a JD from Columbia Law School and BA from Harvard College. Boris Jordan is the founder, President and CEO of The Sputnik Group, a private equity and advisory group with over $1 billion under management. Sputnik’s investments currently span 10 industries across United States, Europe and the CIS. Boris Jordan is also the President of Renaissance Insurance, a leading regional insurance and asset management business, with over $1 billion in revenue. Boris Jordan was co-founder and CEO of Renaissance Capital Group, Russia's first international investment bank. As Deputy Director of the Duke Cancer Institute, Dr. Steven Patierno helps lead a top-ranked NCI-designated Comprehensive Cancer Center dedicated to providing leading-edge compassionate care from diagnosis to treatment to survivorship, advancing multi- and transdisciplinary cancer research and engaging in authentic prevention and community health programming. One of the original eight NCI-designated comprehensive cancer centers, DCI is one of only 41 such centers in the U.S., with more than 65,000 patient visits and 6,500 new cancer diagnoses annually and nearly 1,000 active clinical trials. The DCI includes more than 360 investigators with more than $225 million in annual cancer research funding. Prior to joining Duke, Dr. Steven Patierno served as Executive Director of the George Washington University Cancer Center, the Vivian Gill Distinguished Professor of Oncology and Professor of Pharmacology and Physiology, Genetics and Urology in the GWU School of Medicine and Health Sciences. Portfolio Operating Company Attributes Unparalleled Product Safety and Consistency Standards Internal and independent laboratory-tested products for purity and safety Uniquely consistent product delivery Ability to produce high demand, pharmaceutical-grade medical cannabis products PalliaTech scientists are industry leaders in extracting techniques and formulating branded products Exceptional Product Testing Database provides a unique understanding of how specific medical conditions interact with cannabis chemotypes and strain profiles Superior extraction and formulation methodologies for production of quality product at competitive pricing; generous subsidy programs and above-average margins Interested in an exciting career in cannabis? We are experiencing rapid growth and have fulfilling and interesting opportunities at locations throughout the US. Join our team and make a real impact in a fast-paced high-growth organization. We encourage you to apply to the current openings listed below by forwarding your resume and cover letter to best and most trusted cannabis-based company in the U.S. by: Delivering exceptional user experiences by continually innovating high quality, reliable cannabis products and services Empowering patients and consumers by being the industry’s leading educational resource, allowing them to make the best product choices Stuart is a seasoned operational leader with over 25 years of expertise in global supply chain, operations start-up, acquisitions, and new product commercialization at market leaders. He joined PalliaTech from Hostess Brands where he was the SVP/COO of Operations for the past two years. Prior to Hostess, he held global senior operational leadership positions at The Original Cakerie, a private Canadian company, Fresh Express/ Chiquita and ConAgra. Stuart holds a Bachelor’s degree in Mechanical Engineering Technologies from University of Toledo and a Master’s of Science from Central Michigan University.

KEY FACTS ABOUT CURALEAF, INC.

Company name
CURALEAF, INC.
Status
Active
Filed Number
F17000004987
FEI Number
273631491
Date of Incorporation
November 3, 2017
Age - 7 years
Home State
DE
Company Type
Foreign for Profit

CONTACTS

Website
http://palliatech.com
Phones
(781) 451-0150

CURALEAF, INC. NEAR ME

Principal Address
301 Edgewater Place,
Suite 405,
Wakefield,
MA,
01880,
US

See Also

Officers and Directors

The CURALEAF, INC. managed by the three persons from New York, Wakefield on following positions: Dire

d Kremer E

Position
Dire Active
From
New York, NY, 10170

atthew Darin M

Position
Dire Active
From
New York, NY, 10170

Kevin Gilmore

Position
Dire Active
From
Wakefield, MA, 01880





Registered Agent is CORPORATION SERVICE COMPANY

Address
1201 HAYS STREET, TALLAHASSEE, FL, 32301

Events

November 7, 2018
NAME CHANGE AMENDMENT

Annual Reports

2024
February 8, 2024
2023
March 13, 2023